Genocea Biosciences reported $20.14M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US $ 247.71M 44.22M
Baxter International BAX:US $ 2294M 657M
Bluebird Bio BLUE:US $ 106.26M 54.9M
Cytokinetics CYTK:US $ 115.42M 2.76M
Cytori Therapeutics CYTX:US $ 21.24M 2.84M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Glaxosmithkline GSK:US $ 10967M 6693M
Infinity Pharmaceuticals INFI:US $ 53.12M 27.6M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Moderna Inc MRNA:US 5.05B 1.8B
Novavax NVAX:US $ 1570.95M 1209.13M
Pfizer PFE:US $ 2470M 526M
Prothena PRTA:US $ 542.99M 36.1M